Premium Information is available for this item - Upgrade for $1 a day
6505-00-990-8887
Usp Warfarin Sodium Tablets
6505009908887 009908887 C0UMADIN2045
INC: 27974 Warfarin Sodium Tablets
January 2023
5
Marketplace 6505-00-990-8887
Request a Quotation from participating marketplace vendors
Related Documents 6505-00-990-8887 5+ Documents (More...)
Usp Warfarin Sodium Tablets 6505009908887 6505-00-990-8887 5+ Documents ( More... ) https//www.nsnlookup.com
Usp Warfarin Sodium Tablets 6505009908887 6505015730875 Warfarin Sodium Tablets 6505009908887 https
Usp Warfarin Sodium Tablets 6505009908887 8887 5+ Documents ( More... ) https//www.nsnlookup.com
Usp Warfarin Sodium Tablets 6505009908887 6505015730875 www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00
fsg-65/fsc-6505/us 6505-00-482-2725 Usp Warfarin Sodium Tablets 6505004822725 COUMADIN Tablets 6505009908887
6505010522857 https//www.nsnlookup.com / https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-990-8887
Usp Warfarin Sodium Tablets 6505009908887 Usp Warfarin Sodium Tablets 6505010522856 6505330033376
https// fsc-6505/us 6505-01-052-2856 https Tablets 6505009908887 /fsg-65/fsc-6505/us 6505-01-052-2857
Usp Warfarin Sodium Tablets 6505009908887 /fsg-65/fsc-6505/us 6505-01-052-2857 Usp Warfarin Sodium
Related Documents COUMADIN https https -01-326-1598 RQST NE Related Documents COUMADIN Tablets 6505009908887
Restrictions 6505-00-990-8887
6505-00-990-8887 is a Usp Warfarin Sodium Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-00-990-8887
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-00-990-8887
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-00-990-8887
- Part Number
- Manufacturer
- Status
- C0UMADIN2045
- Manufacturer
- 04490 - Bristol-Myers Squibb Pharma Company (Active)
- Incomplete Reference
- Incomplete Reference
Datasheet 6505-00-990-8887
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Active Medicament Medicinal Strength [AKJA]
- 2.000 Milligrams Warfarin Sodium Active Ingredient
- Administration [CSGS]
- Oral
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 1000.000 Tablets
Management Data 6505-00-990-8887
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Oct 1991
- Veterans Administration (VA)
- BT
- Subscribe
- BT
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 1000 Tt
- 00000001000TT
- K
Similar Supply Items to 6505-00-990-8887
Freight Information 6505-00-990-8887
6505-00-990-8887 has freight characteristics.. 6505-00-990-8887 has a variance between NMFC and UFC when transported by rail and the description should be consulted.